Meanwhile, translating other promising preclinical findings, such as those involving BPC-157, to clinical practice requires thorough investigation to ensure safety and efficacy
#medicine #medical #clinical #hospital #pharmacy #patient #care #mtm #linkedin #healthcare #medications To view or add a comment, sign in Colchicine doesn't seem to help with long COVID Colchicine is not an effective treatment for long COVID, according to Aussie and international research which says we need to explore other therapies
Semaglutide and tirzepatide work primarily through central nervous system mechanisms: appetite suppression in the hypothalamus, modification of food reward signaling in the brainstem, slowed gastric emptying that prolongs satiety
PDD requires fewer symptoms (at least two alongside depressed mood) but for a much longer time: at least two continuous years, with no more than two symptom-free months at a stretch
They study authors wrote: Neuropsychiatric symptoms are a well-described side effect of systemic corticosteroid therapy and can range from mild to severe. In this case including psychosis
The advantages of this treatment include: Long-term weight loss One weekly injection Reduced appetite Increased Metabolism Improved overall health GLP-1 B12 Injection Consultation Your GLP-1-B12 journey begins with a consultation
